Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00801164 · ClinicalTrials.gov registry record · Phase 1
Exploratory Study of Iocide Oral Rinse in a Diabetic Population
A Phase 1 study, sponsored by Biomedical Development Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00801164 is a Phase 1 study that has completed, run by Biomedical Development Corporation. The registered enrollment target is 30 participants.
The verdict
NCT00801164, a Phase 1 study, has completed, sponsored by Biomedical Development Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goals of this exploratory study are to 1)examine an investigational oral rinse as an adjunctive agent to scaling and root planing in treating chronic periodontitis in a periodontitis-susceptible diabetes population, and 2) evaluate its effect on glycemic control and biomarkers of systemic inflammation.
Interventions
- DRUG Frio Mouth Rinse
- DRUG Frio Mouth Rinse Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00801164
The ClinicalTrials.gov registry entry for NCT00801164 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biomedical Development Corporation, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Frio Mouth Rinse is the first listed.
NCT00801164 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00801164 about?
NCT00801164 is a clinical study titled "Exploratory Study of Iocide Oral Rinse in a Diabetic Population". The goals of this exploratory study are to 1)examine an investigational oral rinse as an adjunctive agent to scaling and root planing in treating chronic periodontitis in a periodontitis-susceptible diabetes population, and 2) evaluate its effect on glycemic control and biomarkers of systemic inflam...
What is the current status of trial NCT00801164?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2008-12. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00801164?
The interventions under investigation include: Frio Mouth Rinse (DRUG), Frio Mouth Rinse Placebo (DRUG).
Who is sponsoring clinical trial NCT00801164?
This trial is sponsored by Biomedical Development Corporation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.